Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone and Hyaluronic Acid for Post-extraction Complications
NCT04816253Completed
- Sponsor
- Al-Azhar University
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of methylprednisolone and hyaluronic acid in Impacted Mandibular Third Molar (IM3M) (4 arms), sponsored by Al-Azhar University. Primary endpoints: Interincisal distance at 7 days, Assessment of pain using Visual analog scale at 7 days and 2 more. Started Feb 2021; status: completed.
02
Drugs
methylprednisolonehyaluronic acid
03
Conditions
Impacted Mandibular Third Molar (IM3M)
Beyond the preview
Go deeper on NCT04816253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04816253.